Shanghai Haohai Biological Technology Co., Ltd.
Research Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) on Bullrun: market cap HKD 3.50B, P/E 21.1, dividend yield 6.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6826.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyHKD
- Market capHKD 3.50B
- P/E21.1
- Dividend yield6.3%
- Financial periodFY2025
- RevenueCNY 2.45B
- Revenue growth-8.7%
- Net incomeCNY 251.01M
- Free cash flowCNY 304.04M
- Gross margin70.0%
Valuation Snapshot
latest market cap is HKD 3.50B; P/E is 21.1; dividend yield is 6.3%.
Peer valuation comparison
Latest P/E is 21.09x versus a Healthcare sector median of 21.69x (2.8% below).
Latest dividend yield is 6.27% versus a Healthcare sector median of 2.41% (160.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 2.45B | CNY 251.01M | CNY 304.04M | 70.0% | 1.08 | CNY 2.45B | CNY 398.50M | CNY 5.42B |
| FY2024 | CNY 2.68B | CNY 420.45M | CNY 285.08M | 69.7% | 1.8 | CNY 2.63B | CNY 448.43M | CNY 5.58B |
| FY2023 | CNY 2.63B | CNY 416.12M | CNY 367.22M | 70.3% | 1.74 | CNY 2.74B | CNY 407.95M | CNY 5.65B |
| FY2022 | CNY 2.10B | CNY 180.47M | -CNY 85.85M | 68.8% | 0.74 | CNY 2.54B | CNY 118.26M | CNY 5.51B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 3.50B | 21.1 | 6.3% | 0.98 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.98 HKD, yield 6.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.09 CNY |
| FY2024 | 1.54 CNY |
| FY2023 | 0.32 CNY |
| FY2022 | 0.59 CNY |
About Shanghai Haohai Biological Technology Co., Ltd.
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Shanghai Haohai Biological Technology Co., Ltd.'s market cap?
Shanghai Haohai Biological Technology Co., Ltd.'s market capitalization is HKD 3.50B.
What is Shanghai Haohai Biological Technology Co., Ltd.'s P/E ratio?
Shanghai Haohai Biological Technology Co., Ltd.'s price-to-earnings (P/E) ratio is 21.1.
Does Shanghai Haohai Biological Technology Co., Ltd. pay a dividend?
Shanghai Haohai Biological Technology Co., Ltd. has a dividend yield of 6.3%.
What does Shanghai Haohai Biological Technology Co., Ltd. do?
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequency, and ultrasonic instruments.